NCT07402772Not yet recruiting
Female Osteoporosis
Performance of the Osteoporosis Self-Assessment Tool (OST) and Osteoporosis Risk Assessment Index (ORAI) in Predicting Osteoporosis in Postmenopausal Turkish Women
Source: ClinicalTrials.gov · Last updated 11 Feb 2026
Brief summary (registry, in English)
The aim of this study is to compare the Osteoporosis Risk Assessment Tool and the Osteoporosis Self-Assessment Tool with the gold standard DEXA in determining the risk of osteoporosis in the lumbar and femoral regions in female individuals in the Turkish population, and to investigate their sensitivity and specificity in the first stage of screening for the detection of female osteoporosis.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 1500 (estimated)
- First submitted
- 4 Feb 2026
- Start date
- 4 Feb 2026
- Primary completion date
- 4 Feb 2026
- Lead sponsor
- Kayseri City Hospital
- Diseases
- Osteoporosis
- NCT number
- NCT07402772
What you commit to
- Study type: Observational
- Planned participants: 1500
- From 4 Feb 2026 to the primary completion date, 4 Feb 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with uncontrolled severe comorbid conditions
- Patients with a history of pathological fractures
Age
- Patients younger than 50 or older than 75 years of age
Other
- Patients with secondary osteoporosis
- Male patients
Who the study is looking for
- Postmenopausal women aged 50-75
- Patients who underwent imaging with the STRATOS DEXA device at Kayseri City Hospital
Age in the registry: 50 years to 75 years · Sex: Female · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.